Altimmune’s lead drug Pemvidutide demonstrates significant progress in obesity and liver health. See why ALT stock is a ...

Obesity, alcohol use and other factors are driving up rates of fatty liver disease among American adults, new research warns.

Hepatocellular carcinoma, a type of liver cancer, is the sixth most common cancer worldwide and the third leading cause of ...

Monitoring liver cell senescence could help to identify those most at ... discovery research and finding insights into life, ...

Liver cancer remains one of the most aggressive forms of cancer, often detected only in later stages when treatment options ...

Bilirubin, the byproduct of hemoprotein breakdown, particularly hemoglobin, is a critical marker in diagnosing, prognosing, ...

The aging and failure of cells that occurs when the liver is damaged can spread to other organs, suggests a new study in mice ...

If you’re looking for a feel-good way to shrink your waist, “then let’s show your liver some love,” suggests Radical ...

On Friday, Vir Biotechnology, Inc. (NASDAQ:VIR) announced end-of-treatment data from Part B of the MARCH Phase 2 study ...